NO921852L - N-substituerte azaheterosykliske karboksylsyrer og en farmasoeytisk sammensetning - Google Patents
N-substituerte azaheterosykliske karboksylsyrer og en farmasoeytisk sammensetningInfo
- Publication number
- NO921852L NO921852L NO92921852A NO921852A NO921852L NO 921852 L NO921852 L NO 921852L NO 92921852 A NO92921852 A NO 92921852A NO 921852 A NO921852 A NO 921852A NO 921852 L NO921852 L NO 921852L
- Authority
- NO
- Norway
- Prior art keywords
- carboxylic acids
- image
- substituted
- pharmaceutical composition
- alkyl
- Prior art date
Links
- 150000001735 carboxylic acids Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 230000000946 synaptic effect Effects 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK588189A DK588189D0 (da) | 1989-11-22 | 1989-11-22 | Nye heterocykliske carboxylsyrer |
| PCT/DK1990/000302 WO1991007389A1 (en) | 1989-11-22 | 1990-11-22 | N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO921852L true NO921852L (no) | 1992-05-11 |
| NO921852D0 NO921852D0 (no) | 1992-05-11 |
| NO177853B NO177853B (no) | 1995-08-28 |
| NO177853C NO177853C (no) | 1995-12-06 |
Family
ID=8145900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO921852A NO177853C (no) | 1989-11-22 | 1992-05-11 | Analogifremgangsmåter for fremstilling av N-substituerte azaheterocykliske karboksylsyrer |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5198451A (no) |
| EP (1) | EP0502031B1 (no) |
| JP (1) | JPH05503083A (no) |
| AT (1) | ATE157086T1 (no) |
| AU (1) | AU660919B2 (no) |
| CA (1) | CA2073189C (no) |
| DE (1) | DE69031312T2 (no) |
| DK (2) | DK588189D0 (no) |
| FI (1) | FI97541C (no) |
| IE (1) | IE904155A1 (no) |
| IL (2) | IL96370A (no) |
| NO (1) | NO177853C (no) |
| NZ (1) | NZ236155A (no) |
| PT (1) | PT95970B (no) |
| WO (1) | WO1991007389A1 (no) |
| ZA (1) | ZA909305B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK74693D0 (da) * | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
| US5962449A (en) | 1995-04-07 | 1999-10-05 | Novo Nordisk A/S | Tricyclic compounds in treating hyperalgesic conditions and NIDDM |
| ES2297859T3 (es) * | 1996-05-24 | 2008-05-01 | Smithkline Beecham Corporation | Uso de inhibidores de la captacion de gaba como agentes antitusivos. |
| DE10204496A1 (de) * | 2002-02-04 | 2003-08-21 | Msa Auer Gmbh | Vorrichtung zur Dosierung gas- und/oder dampfförmiger Stoffe |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4383999A (en) * | 1981-05-26 | 1983-05-17 | Smithkline Beckman Corporation | Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters |
| DK704488D0 (da) * | 1988-12-19 | 1988-12-19 | Novo Industri As | Nye n-substituerede azaheterocykliske carboxylsyrer |
| DK288385D0 (da) * | 1985-06-26 | 1985-06-26 | Novo Industri As | Aminosyrederivater |
| US4910312A (en) * | 1985-11-08 | 1990-03-20 | Warner-Lambert Company | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof |
| FI864246A (fi) * | 1985-11-08 | 1987-05-09 | Warner Lambert Co | N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat. |
| US4772615A (en) * | 1985-11-08 | 1988-09-20 | Warner-Lambert Company | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof |
| ES2059360T3 (es) * | 1986-01-07 | 1994-11-16 | Novo Nordisk As | Nuevos derivados de aminoacidos. |
| US5006560A (en) * | 1989-12-20 | 1991-04-09 | Schering Corporation | Use of GABA-B selective agonists as anti-tussive agents |
-
1989
- 1989-11-22 DK DK588189A patent/DK588189D0/da not_active Application Discontinuation
-
1990
- 1990-11-16 IL IL9637090A patent/IL96370A/en not_active IP Right Cessation
- 1990-11-16 IL IL69370A patent/IL96370A0/xx unknown
- 1990-11-19 IE IE415590A patent/IE904155A1/en unknown
- 1990-11-20 ZA ZA909305A patent/ZA909305B/xx unknown
- 1990-11-20 NZ NZ236155A patent/NZ236155A/xx unknown
- 1990-11-20 US US07/616,165 patent/US5198451A/en not_active Expired - Fee Related
- 1990-11-22 DK DK90917178.7T patent/DK0502031T3/da active
- 1990-11-22 AU AU67464/90A patent/AU660919B2/en not_active Ceased
- 1990-11-22 PT PT95970A patent/PT95970B/pt active IP Right Grant
- 1990-11-22 EP EP90917178A patent/EP0502031B1/en not_active Expired - Lifetime
- 1990-11-22 JP JP3500073A patent/JPH05503083A/ja active Pending
- 1990-11-22 AT AT90917178T patent/ATE157086T1/de active
- 1990-11-22 WO PCT/DK1990/000302 patent/WO1991007389A1/en active IP Right Grant
- 1990-11-22 DE DE69031312T patent/DE69031312T2/de not_active Expired - Fee Related
- 1990-11-22 CA CA002073189A patent/CA2073189C/en not_active Expired - Fee Related
-
1992
- 1992-05-11 NO NO921852A patent/NO177853C/no unknown
- 1992-05-19 FI FI922268A patent/FI97541C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| NO177853C (no) | 1995-12-06 |
| CA2073189A1 (en) | 1991-05-23 |
| DE69031312T2 (de) | 1998-02-26 |
| US5198451A (en) | 1993-03-30 |
| PT95970B (pt) | 1998-01-30 |
| AU6746490A (en) | 1991-06-13 |
| IL96370A0 (en) | 1991-08-16 |
| IL96370A (en) | 1995-01-24 |
| DK588189D0 (da) | 1989-11-22 |
| NO921852D0 (no) | 1992-05-11 |
| CA2073189C (en) | 1998-04-07 |
| FI922268A0 (fi) | 1992-05-19 |
| IE904155A1 (en) | 1991-05-22 |
| FI97541B (fi) | 1996-09-30 |
| JPH05503083A (ja) | 1993-05-27 |
| FI922268L (fi) | 1992-05-19 |
| AU660919B2 (en) | 1995-07-13 |
| EP0502031B1 (en) | 1997-08-20 |
| DE69031312D1 (de) | 1997-09-25 |
| EP0502031A1 (en) | 1992-09-09 |
| PT95970A (pt) | 1991-09-13 |
| WO1991007389A1 (en) | 1991-05-30 |
| FI97541C (fi) | 1997-01-10 |
| ATE157086T1 (de) | 1997-09-15 |
| ZA909305B (en) | 1991-09-25 |
| NZ236155A (en) | 1993-04-28 |
| NO177853B (no) | 1995-08-28 |
| DK0502031T3 (da) | 1998-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO894013D0 (no) | Fremgangsmaate for fremstilling av peptidase-inhibitorer. | |
| FI962749A0 (fi) | Uusia heterosyklisiä yhdisteitä | |
| MX9707531A (es) | Nuevos compuestos heterociclicos. | |
| HUT64842A (en) | Method for producing pharmaceutical preparatives containing 2-[n-(2-amino-ethyl)-amino]-acetic acid derivatives | |
| FI93646B (fi) | Menetelmä terapeuttisesti käyttökelpoisten oligopeptidien valmistamiseksi, joissa on proliinille analogisia syklisiä aminohappoja | |
| HUT57773A (en) | Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds | |
| KR870004955A (ko) | 다양한 n-치환된 3-피페리딘카복실산 또는 n-치환된 3-피리딘카복실산 및 당해 유도체 | |
| NO921852D0 (no) | N-substituerte azaheterosykliske karboksylsyrer og en farmasoeytisk sammensetning | |
| FI101301B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi | |
| DK0599240T3 (da) | Indol-7-carboxamidderivater som analgetika | |
| DK149133C (da) | Analogifremgangsmaade til fremstilling af 2-(4-(diphenylmethylen)- l-piperidinyl)- eddikesyrer eller farmaceutisk acceptable salte heraf | |
| LV11689A (lv) | 4-Ú(2-benzotiazolil)metilamino¾-alfa-Ú(3,4-difluorfenoksi)metil¾-1-piperidinetanols | |
| ATE116974T1 (de) | 5- piperazinylalkyl-1,5-benzothiazepinone verwendbar als calciumantagonisten. | |
| PT1021404E (pt) | Derivados de azetidinona para o tratamento de infeccoes pelo hcmv | |
| ATE212637T1 (de) | Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung | |
| ES2054989T3 (es) | Derivados de aminodiol inhibidores de renina. | |
| DE3863214D1 (de) | Glutaminsaeurederivate, ihre salze, verfahren zu ihrer herstellung, verwendung als arzneimittel und diese enthaltende zusammensetzungen. | |
| KR960704888A (ko) | AMPA-수용체에 작용하는 알콕시-치환 β-카르보린 (Alkoxy-Substituted β-Carbolines Acting on The AMPA-Receptor) | |
| ATE229495T1 (de) | Verfahren zur herstellung von n-acyl- aminosäureestern und n-acyl-aminoacetalen |